Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;96:3696-3703

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toyama, J.
Right arrow Articles by Kodama, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toyama, J.
Right arrow Articles by Kodama, I.

(Circulation. 1997;96:3696-3703.)
© 1997 American Heart Association, Inc.


Articles

Vesnarinone Prolongs Action Potential Duration Without Reverse Frequency Dependence in Rabbit Ventricular Muscle by Blocking the Delayed Rectifier K+ Current

Junji Toyama, MD; Kaichiro Kamiya, MD; Jianhua Cheng, MD, PhD; Jong-Kook Lee, MD; Ryoko Suzuki, BSc; ; Itsuo Kodama, MD

From the Department of Circulation (J.T., K.K., J.C., J.K.L.) and the Department of Humoral Regulation (R.S., I.K.), Research Institute of Environmental Medicine, Nagoya (Japan) University.

Correspondence to Kaichiro Kamiya, MD, Department of Circulation, Research Institute of Environmental Medicine, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, 464–01 Japan.

Background Methanesulfonanilide derivatives, selective inhibitors of the rapidly activating component (IKr) of the delayed rectifier potassium current (IK), prolong action potential duration (APD) of cardiac muscles with reverse frequency dependence, which limits their clinical use because of proarrhythmia. Vesnarinone, a quinolinone derivative developed as a cardiotonic agent, has complex pharmacological properties, but its clinical efficacy is explained in part by IK reduction. Therefore, we investigated the mode of IK block by vesnarinone.

Methods and Results IK of the rabbit ventricular myocyte was activated by voltage-clamp steps applied from a holding potential to various depolarizing levels. The development of IK block at depolarization (+10 mV) and its recovery process at hyperpolarization (-75 mV) were compared between vesnarinone and E-4031. The IK block by vesnarinone (3 µmol/L) developed and recovered monoexponentially, with time constants of 361 ms (n=5) and 1.87 seconds (n=4), respectively. IK block by E-4031 (0.3 µmol/L) developed instantaneously, with no recovery from the block at hyperpolarization. The IK block by vesnarinone, estimated by IK tail after a train of depolarizing pulses (for 30 seconds at 0.2 to 2 Hz), was increased with increasing frequency (twofold at 2 from 0.2 Hz), but that by E-4031 was unchanged. In rabbit papillary muscles, vesnarinone (10 µmol/L) prolonged APD at stimulation frequencies >0.2 Hz, whereas E-4031 (0.3 µmol/L) prolonged that in a reverse frequency-dependent manner.

Conclusions Vesnarinone may prolong the repolarization of human cardiac muscle without reverse frequency dependence, because IKr is expressed in humans as well as in the rabbit. Thus, this drug may be a model for an ideal class III drug without the risk of proarrhythmia.


Key Words: arrhythmia • potassium channels • action potentials




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Tsujimae, S. Suzuki, S. Murakami, and Y. Kurachi
Frequency-dependent effects of various IKr blockers on cardiac action potential duration in a human atrial model
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H660 - H669.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Z. Lu, K. Kamiya, T. Opthof, K. Yasui, and I. Kodama
Density and Kinetics of IKr and IKs in Guinea Pig and Rabbit Ventricular Myocytes Explain Different Efficacy of IKs Blockade at High Heart Rate in Guinea Pig and Rabbit: Implications for Arrhythmogenesis in Humans
Circulation, August 21, 2001; 104(8): 951 - 956.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. Kamiya, J. S. Mitcheson, K. Yasui, I. Kodama, and M. C. Sanguinetti
Open Channel Block of HERG K+ Channels by Vesnarinone
Mol. Pharmacol., August 1, 2001; 60(2): 244 - 253.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Katayama, A. Fujita, T. Ohe, I. Findlay, and Y. Kurachi
Inhibitory Effects of Vesnarinone on Cloned Cardiac Delayed Rectifier K+ Channels Expressed in a Mammalian Cell Line
J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 339 - 346.
[Abstract] [Full Text]